Kenneth A. Skau

829 total citations
43 papers, 707 citations indexed

About

Kenneth A. Skau is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, Kenneth A. Skau has authored 43 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Pharmacology and 7 papers in Physiology. Recurrent topics in Kenneth A. Skau's work include Cholinesterase and Neurodegenerative Diseases (15 papers), Pesticide Exposure and Toxicity (7 papers) and Ion channel regulation and function (6 papers). Kenneth A. Skau is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (15 papers), Pesticide Exposure and Toxicity (7 papers) and Ion channel regulation and function (6 papers). Kenneth A. Skau collaborates with scholars based in United States, Czechia and Norway. Kenneth A. Skau's co-authors include Stephen Brimijoin, David J. Wells, Per Sidenius, Johannes Jakobsen, Michael C. Gerald, Lane J. Wallace, Michael T. Shipley, Matthew Ennis, Elizabeth M. Kudlacz and Cecilia M. Fenoglio‐Preiser and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Physiology.

In The Last Decade

Kenneth A. Skau

40 papers receiving 669 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenneth A. Skau United States 16 233 186 183 155 111 43 707
S.K. Kulkarni India 20 103 0.4× 357 1.9× 237 1.3× 124 0.8× 63 0.6× 46 1.1k
André Sampaio Pupo Brazil 19 60 0.3× 302 1.6× 469 2.6× 164 1.1× 42 0.4× 53 1.1k
Kumar V.S. Nemmani India 20 172 0.7× 237 1.3× 441 2.4× 335 2.2× 35 0.3× 39 1.2k
Sonja Vučković Serbia 17 292 1.3× 298 1.6× 234 1.3× 444 2.9× 44 0.4× 75 1.0k
Jan M. Keppel Hesselink Germany 21 314 1.3× 174 0.9× 185 1.0× 448 2.9× 64 0.6× 98 1.2k
Elliot M. Berry Israel 21 461 2.0× 225 1.2× 228 1.2× 329 2.1× 77 0.7× 49 1.4k
Inmaculada Bellido-Estévez Spain 15 121 0.5× 268 1.4× 216 1.2× 68 0.4× 62 0.6× 35 773
Gregory C. Janis United States 15 143 0.6× 550 3.0× 277 1.5× 70 0.5× 18 0.2× 29 1.3k
M. Pomponi Italy 15 217 0.9× 167 0.9× 155 0.8× 149 1.0× 46 0.4× 40 861
Yaoyu Pu Japan 23 445 1.9× 210 1.1× 774 4.2× 267 1.7× 68 0.6× 42 1.8k

Countries citing papers authored by Kenneth A. Skau

Since Specialization
Citations

This map shows the geographic impact of Kenneth A. Skau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth A. Skau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth A. Skau more than expected).

Fields of papers citing papers by Kenneth A. Skau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth A. Skau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth A. Skau. The network helps show where Kenneth A. Skau may publish in the future.

Co-authorship network of co-authors of Kenneth A. Skau

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth A. Skau. A scholar is included among the top collaborators of Kenneth A. Skau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth A. Skau. Kenneth A. Skau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martin, Beth A., et al.. (2015). Developing the reflective practitioner: what, so what, now what. Currents in Pharmacy Teaching and Learning. 7(5). 705–715. 14 indexed citations
2.
Skau, Kenneth A., et al.. (2009). Learning Across the Curriculum: Connecting the Pharmaceutical Sciences to Practice in the First Professional Year. American Journal of Pharmaceutical Education. 73(2). 36–36. 26 indexed citations
3.
Skau, Kenneth A.. (2007). Pharmacy Is a Science-based Profession. American Journal of Pharmaceutical Education. 71(1). 11–11. 17 indexed citations
4.
Leslie, Steven W., Diane E. Beck, Timothy J. Ives, et al.. (2003). Final Report of the 2002–2003 Bylaws and Policy Development Committee. American Journal of Pharmaceutical Education. 67(3). S04–S04. 2 indexed citations
5.
Skau, Kenneth A. & Michael T. Shipley. (1999). Phenylmethylsulfonyl fluoride inhibitory effects on acetylcholinesterase of brain and muscle. Neuropharmacology. 38(5). 691–698. 7 indexed citations
6.
Skau, Kenneth A., et al.. (1998). Age-related changes in activity of fischer 344 rat brain acetylcholinesterase molecular forms. Molecular and Chemical Neuropathology. 35(1-3). 13–21. 8 indexed citations
7.
Heyliger, Clayton E., et al.. (1997). Characteristics of the myocardial PM-FABP: Effect of diabetes mellitus. Molecular and Cellular Biochemistry. 176(1-2). 281–286. 6 indexed citations
8.
Skau, Kenneth A., et al.. (1995). Munchausen syndrome by proxy: a review. Acta Paediatrica. 84(9). 977–982. 16 indexed citations
9.
Heyliger, Clayton E., David M. Powell, & Kenneth A. Skau. (1995). Effect of hydralazine on myocardial plasma membrane fatty acid binding protein (PM-FABP) during diabetes mellitus. Molecular and Cellular Biochemistry. 148(1). 39–44. 6 indexed citations
10.
Cacini, William, et al.. (1993). Reduced Renal Accumulation and Toxicity of Cisplatin in Experimental Galactosemia. Experimental Biology and Medicine. 203(3). 348–353. 12 indexed citations
11.
Coats, Eugene A., et al.. (1993). Exploring the Hexokinase Glucose Binding Site Through Correlation Analysis and Molecular Modeling of Glucosamine Inhibitors. Journal of enzyme inhibition. 6(4). 271–282. 4 indexed citations
12.
Hertelendy, Zsolt, et al.. (1992). Progressive and concurrent deterioration of vagus-stimulated and hypoglycemia-induced glucagon secretion in streptozotocin-diabetic rats. European Journal of Endocrinology. 126(1). 80–84. 12 indexed citations
13.
Skau, Kenneth A.. (1989). Distribution and solubilization of the molecular forms of acetylcholinesterase in rat urinary bladder and sphincter. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 995(2). 195–200. 2 indexed citations
14.
Skau, Kenneth A., et al.. (1988). Determination of vagal stimulated glucagon release in diabetic rats. The FASEB Journal. 2(5). 7538.
15.
Skau, Kenneth A.. (1985). Acetylcholinesterase molecular forms in serum and erythrocytes of laboratory animals. Comparative Biochemistry and Physiology Part C Comparative Pharmacology. 80(1). 207–210. 16 indexed citations
16.
Skau, Kenneth A.. (1983). The acetylcholinesterase abnormality in dystrophic mice is a reflection of a maturational defect. Brain Research. 276(1). 192–194. 15 indexed citations
17.
Gerald, Michael C., Michael J. Meldrum, & Kenneth A. Skau. (1982). Biphasic amphetamine effects on skeletal muscle contractions: noncholinergic mechanisms.. PubMed. 35(1). 3–16. 2 indexed citations
18.
Skau, Kenneth A. & Stephen Brimijoin. (1980). Multiple Molecular Forms of Acetylcholinesterase in Rat Vagus Nerve, Smooth Muscle, and Heart. Journal of Neurochemistry. 35(5). 1151–1154. 30 indexed citations
19.
Dyck, Peter James, Edward H. Lambert, Christopher Calder, et al.. (1980). Nitrous Oxide Neurotoxicity Studies in Man and Rat. Anesthesiology. 53(3). 205–209. 19 indexed citations
20.
Gerald, Michael C., Kenneth A. Skau, & Roger P. Maickel. (1972). Effects of various antihistamines on oxotremorine-induced hypothermia in mice. European Journal of Pharmacology. 17(1). 189–193. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026